Cream4349

XERS Sept 10th PDUFA potential run up.

Long
NASDAQ:XERS   Xeris Biopharma Holdings, Inc.
I bought XERS initially at 9.23 and have since then swung it from 11.50 to 12.50+ area. I believe it is heading into a short term bear trend which will precipitate a run up to the FDA PDUFA approval of it's diabetic non inject able. Short ratio is up as well.

I marked the resistance and support points that I think are major. There are no triangles to work off of only resistance and support points as well as moving averages. I will look to re-buy when i see a strong reversal from either the 9.30 or 10.50 areas. GLTA!

Hope you enjoy!

Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.